Cardiac Science Acquisition Approved
- Share via
A Times Staff Writer
Defibrillator maker Cardiac Science Inc. said this week that shareholders have approved the Irvine company’s acquisition of Survivalink Corp., a Minneapolis maker of external defibrillators, for $71 million in cash and stock.
Shareholders also approved an increase in the number of authorized shares to a maximum of 100 million from 40 million, Cardiac said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
